Respiratory Syncytial Virus (RSV)

Respiratory Syncytial Virus (RSV)

Latest Posts

Quick takes: EMA lifts chikungunya vaccine restriction, another Nipah case from India, expanded indication review for Arexvy​
New data reveal impact of RSV on kids with chronic conditions, plus high adult exposure​
Shingles, RSV vaccines may protect older adults from dementia​
RSV hospitalization in adults tied to risk of death and kidney, heart problems​
ACIP draft agenda revives anti-vaccine boilerplate topics​
Moderna receives expanded approval for RSV vaccine​
FDA approves Merck RSV monoclonal antibody shot for infants​
Flu, RSV linked to higher odds of secondary bacterial infection​
Study details economic impact of RSV infections in young children​
Studies estimate 75% RSV vaccine efficacy in older adults, profile risk for poor outcomes​
Only 6 symptoms, conditions appear unique to long COVID, suggesting overlap with other post-viral infections​
RSV tied to high complication, death rates in hospitalized older adults​
Quick takes: Re-emergent COVID strain, extended US RSV season, typhus in California​
CDC data suggest flu is on the way out​
RSV vaccination coverage remains low among older US adults​
CDC reports 14 more pediatric flu deaths, 115 total​
FDA approves use of RSV vaccine in at-risk younger adults​
CDC reports 11 more pediatric flu deaths​
Medical societies recommend RSV vaccines for older or immune-compromised adults​
Up to 56,000 people died from COVID-19 or RSV last year​